Minimal residual disease in multiple myeloma: current status

• Main Authors: Hong Ding (Author), Juan Xu (Author), Zhimei Lin (Author), Jingcao Huang (Author), Fangfang Wang (Author), Yan Yang (Author), Yushan Cui (Author), Hongmei Luo (Author), Yuhan Gao (Author), Xinyu Zhai (Author), Weicui Pang (Author), Li Zhang (Author), Yuhuan Zheng (Author)
• Format: Book
• Published: BMC, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Multiple myeloma (MM) is a treatable plasma cell cancer with no cure. Clinical evidence shows that the status of minimal residual disease (MRD) after treatment is an independent prognostic factor of MM. MRD indicates the depth of post-therapeutic remission. In this review article, we outlin...